169 filings
Page 5 of 9
8-K
a8l3v8 ybsh
8 Jan 18
Regulation FD Disclosure
12:00am
8-K
a5ekvx73efogoe
2 Jan 18
Entry into a Material Definitive Agreement
12:00am
8-K
6zm3izda
30 Nov 17
Intrexon Announces Key Management Appointments
12:00am
8-K
7hp30e
9 Nov 17
Intrexon Announces Third Quarter 2017 Financial Results
12:00am
8-K
r9pamb2v3d50mc
16 Oct 17
Entry into a Material Definitive Agreement
12:00am
8-K
uknpgp758f90cbaic6tn
9 Aug 17
Intrexon Announces Second Quarter and First Half 2017 Financial Results
12:00am
8-K
y3sccop31 lnvwqxdt
30 Jun 17
Departure of Directors or Certain Officers
12:00am
8-K
owu 23x0346
16 Jun 17
Intrexon Integrates Leading Adenoviral Gene Delivery Technology with Completion of GenVec Acquisition
12:00am
8-K
p083ijz580hgsrgkelui
10 May 17
Intrexon Announces First Quarter 2017 Financial Results
12:00am
8-K
fl9a ogcqyf55sxfkzbx
27 Apr 17
Intrexon Appoints Vinita Gupta, Leading Pharma Executive, to its Board of Directors
12:00am
8-K
sq60f1p
31 Mar 17
Departure of Directors or Certain Officers
12:00am
8-K
g13i2866p5c
10 Mar 17
Intrexon Creates Precigen, Inc. and Accelerates Strategic Review of Structural Options Related to Health Assets
12:00am
8-K
syd8hb90c0ls2fd9t
1 Mar 17
Intrexon Announces Fourth Quarter and Full Year 2016 Financial Results
12:00am
8-K
lot140ytd
24 Jan 17
Intrexon to Acquire GenVec to Expand Industry-Leading Gene Delivery Platform
12:00am
8-K
o1kvel ccaotc
11 Jan 17
Regulation FD Disclosure
12:00am
8-K
xyug3kv43h83
30 Dec 16
Entry into a Material Definitive Agreement
12:00am
8-K
co2ep dkz
9 Nov 16
Intrexon Announces Third Quarter 2016 Financial Results
12:00am
8-K
2ui1 wszn3a8
3 Nov 16
Entry into a Material Definitive Agreement
12:00am
8-K
t9zgk
9 Aug 16
Intrexon Announces Second Quarter and First Half 2016 Financial Results
12:00am
8-K
vb2 etowgjw
8 Aug 16
Intrexon Appoints Dr. Andrew J. Last as Chief Operating Officer
12:00am